United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Healthcare Industry News FDA approves Cardio Flow Design’s iTFlow for enhanced cardiovascular diagnosis The US Food and Drug Administration (FDA) has granted approval for iTFlow, a software solution developed by Cardio… byPallavi MadhirajuJune 19, 2023